U.S. Food and Drug Administration Coronavirus (COVID-19) Update: December 21, 2020 | site |


(Information contained in U.S. Food and Drug Administration [FDA] press release: December 21, 2020)

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
  • The FDA has posted translations of the Pfizer-BioNTech COVID-19 Vaccine fact sheet for recipients and caregivers in languages including: Arabic, Burmese, Cherokee, Chinese (Simplified and Traditional), Chuukese, German, Haitian Creole, Hindi, Hmong, Korean, Mam, Polish, Portuguese, Russian, Spanish, Somali, Tagalog, Vietnamese, and Yiddish. We will post additional language translations of the fact sheet for recipients and caregivers to this page as we receive the translations.
  • Today, the agency updated its FDA COVID-19 Response At-A-Glance Summary, which provides a quick look at facts, figures, and highlights on the FDA's response efforts.
  • Testing updates:
As of Dec. 21, 306 tests and sample collection devices are authorized by the FDA under emergency use authorizations (EUAs), including 233 molecular tests and sample collection devices, 62 antibody tests, and 11 antigen tests.